Nonthermal, Nontumescent Endovenous Treatment of Varicose Veins
Özet
Background Endothermal treatment of the great saphenous vein has become the first line of treatment for superficial venous reflux. A new technique for venous insufficiency is non-thermal ablation with vein sealing system which comprises the endovenous delivery of cyanoacrylate tissue adhesive to the vein causing fibrosis. Methods This is a single-center prospective study of treatment of great saphenous vein incompetence in 62 patients with vein sealing system (Biolas VariClose® FG Group, Turkey). All cases were implemented under local anesthesia. Tumescent anesthesia was not required. Patients were not given any nonsteroidal anti-inflammatory drug postoperatively; advised to wear elastic bandages for 1 day; and compression stockings were not offered. Results Treatment success was defined as complete occlusion of treated vein or recanalized segment shorter than 5 cm. Subtotal recanalization was defined as great saphenous vein flow containing 5–10 cm segment of treated vein. A recanalized great saphenous vein or treatment failure was defined as an open part of the treated vein segment more than 10 cm in length. At 1 week and 1 month control, duplex scans showed total occlusion for all patients (100%), total occlusion for 58 patients (93.5%), and subtotal occlusion for 4 patients (6.5%) at third month. At the end of 6 months, total occlusion 56 patients (90.3%) and subtotal occlusion for 2 patients (3.2%). For 4 (6.5%) patients, no occlusion was observed, and the diameter was >11 mm. Embolization of great saphenous vein with cyanoacrylate has been performed since the beginning of this decade. Combined chemical and physical mechanism of action results in permanent vein closure. In a recently published study, a 24-month occlusion rate of 92% was demonstrated. The most commonly reported complications of cyanoacrylate use for the treatment of varicose vein disease, so far, include ecchymosis and phlebitis. Almeida et al. reported that phlebitis is the most frequent side effect at a rate of 16%. In our study, phlebitis rate was not as high as reported. It may be caused due to shorter time of follow-up in the hospital. Conclusion Endovenous ablation of incompetent great saphenous vein with cyanoacrylate-based glue is feasible. Operation time is short, and tumescent anesthesia is unnecessary as postprocedure compression stockings. Lack of significant side effects and an yearly success rate of 100% are benefits of the system. © 2016 Elsevier Inc.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Tekin, Ali İhsan | |
| dc.contributor.author | Tuncer, Osman Nuri | |
| dc.contributor.author | Memetoğlu, Mehmet Erdem | |
| dc.contributor.author | Arslan, Ümit | |
| dc.contributor.author | Öztekin, Ahmet | |
| dc.contributor.author | Yağmur, Bayram | |
| dc.contributor.author | Biçer, Mahmut | |
| dc.contributor.author | Özmen, Rıfat | |
| dc.date.accessioned | 2026-10-18T20:29:20.959867281Z | |
| dc.date.available | 2026-10-18T20:29:20.959867281Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Background Endothermal treatment of the great saphenous vein has become the first line of treatment for superficial venous reflux. A new technique for venous insufficiency is non-thermal ablation with vein sealing system which comprises the endovenous delivery of cyanoacrylate tissue adhesive to the vein causing fibrosis. Methods This is a single-center prospective study of treatment of great saphenous vein incompetence in 62 patients with vein sealing system (Biolas VariClose® FG Group, Turkey). All cases were implemented under local anesthesia. Tumescent anesthesia was not required. Patients were not given any nonsteroidal anti-inflammatory drug postoperatively; advised to wear elastic bandages for 1 day; and compression stockings were not offered. Results Treatment success was defined as complete occlusion of treated vein or recanalized segment shorter than 5 cm. Subtotal recanalization was defined as great saphenous vein flow containing 5–10 cm segment of treated vein. A recanalized great saphenous vein or treatment failure was defined as an open part of the treated vein segment more than 10 cm in length. At 1 week and 1 month control, duplex scans showed total occlusion for all patients (100%), total occlusion for 58 patients (93.5%), and subtotal occlusion for 4 patients (6.5%) at third month. At the end of 6 months, total occlusion 56 patients (90.3%) and subtotal occlusion for 2 patients (3.2%). For 4 (6.5%) patients, no occlusion was observed, and the diameter was >11 mm. Embolization of great saphenous vein with cyanoacrylate has been performed since the beginning of this decade. Combined chemical and physical mechanism of action results in permanent vein closure. In a recently published study, a 24-month occlusion rate of 92% was demonstrated. The most commonly reported complications of cyanoacrylate use for the treatment of varicose vein disease, so far, include ecchymosis and phlebitis. Almeida et al. reported that phlebitis is the most frequent side effect at a rate of 16%. In our study, phlebitis rate was not as high as reported. It may be caused due to shorter time of follow-up in the hospital. Conclusion Endovenous ablation of incompetent great saphenous vein with cyanoacrylate-based glue is feasible. Operation time is short, and tumescent anesthesia is unnecessary as postprocedure compression stockings. Lack of significant side effects and an yearly success rate of 100% are benefits of the system. © 2016 Elsevier Inc. | |
| dc.identifier.doi | 10.1016/j.avsg.2016.03.005 | |
| dc.identifier.eissn | 1615-5947 | |
| dc.identifier.endpage | 235 | |
| dc.identifier.issn | 0890-5096 | |
| dc.identifier.pmid | 27421205 | |
| dc.identifier.scopus | 2-s2.0-84992736575 | |
| dc.identifier.startpage | 231 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14537 | |
| dc.identifier.volume | 36 | |
| dc.identifier.wos | WOS:000384959800032 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Inc. | |
| dc.relation.ispartof | Annals of Vascular Surgery | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Anesthesia, Local | |
| dc.subject | Compression Bandages | |
| dc.subject | Cyanoacrylates | |
| dc.subject | Embolization, Therapeutic | |
| dc.subject | Endovascular Procedures | |
| dc.subject | Equipment Design | |
| dc.subject | Feasibility Studies | |
| dc.subject | Female | |
| dc.subject | Fibrosis | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Middle Aged | |
| dc.subject | Miniaturization | |
| dc.subject | Prospective Studies | |
| dc.subject | Saphenous Vein | |
| dc.subject | Time Factors | |
| dc.subject | Treatment Outcome | |
| dc.subject | Turkey | |
| dc.subject | Ultrasonography, Doppler, Duplex | |
| dc.subject | Varicose Veins | |
| dc.subject | Vascular Access Devices | |
| dc.subject | cyanoacrylate | |
| dc.subject | cyanoacrylate derivative | |
| dc.subject | Article | |
| dc.subject | cardiovascular surgical equipment | |
| dc.subject | compression bandage | |
| dc.subject | diabetes mellitus | |
| dc.subject | ecchymosis | |
| dc.title | Nonthermal, Nontumescent Endovenous Treatment of Varicose Veins | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 43 | |
| rdl.citation.wos | 38 | |
| rdl.department | Erzincan University, Mengücek Gazi Training and Research Hospital, Erzincan, Turkey. Electronic address: osnutuncer@gmail.com. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
